AMRI has been named on Forbes’ ‘America’s Best Mid-Sized Employers 2021’ list, in the drugs and biotechnology category.
Its 3,100 employees provide scientific solutions across the R&D and manufacturing continuum to pharmaceutical and biotechnology customers.
AMRI launched its Learning Initiatives for Employees programme, known as LIFE@AMRI, in 2020. The initiative offers a development and performance framework, aiming to provide tools and opportunities for employees across the business. It’s part of the company’s people excellence strategy, focused on building a diverse, inclusive and high-performing culture, it says.
“We constantly strive to create a workplace that is in keeping with the high calibre of our employees and the importance of our patient-centred mission,” said John Ratliff, CEO, AMRI. “Recognition in the Forbes ranking this year is testament to our extraordinary team who, despite the profound challenges the world faced with the COVID-19 pandemic, continued to improve and deliver. I extend my deep gratitude to the AMRI community for your expertise, dedication and agility.”